Table of Contents
ISRN Endocrinology
Volume 2012, Article ID 167318, 8 pages
http://dx.doi.org/10.5402/2012/167318
Research Article

Incidence of Metabolic Syndrome and Its Risk Factors among Type 2 Diabetes Clinic Attenders in Isfahan, Iran

1Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, 8144503500 Isfahan, Iran
2Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, 8144503500 Isfahan, Iran

Received 5 December 2011; Accepted 11 January 2012

Academic Editors: W. B. Chan, T.-H. Tung, and G. Zoppini

Copyright © 2012 Mohsen Janghorbani and Masoud Amini. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. S. Ford, W. H. Giles, and A. H. Mokdad, “Increasing prevalence of the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 27, no. 10, pp. 2444–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. W. Nesto, “Correlation between cardiovascular disease and diabetes mellitus: current concepts,” American Journal of Medicine, vol. 116, no. 5, supplement, pp. 11S–22S, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. M. Ridker, J. E. Buring, N. R. Cook, and N. Rifai, “C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women,” Circulation, vol. 107, no. 3, pp. 391–397, 2003. View at Google Scholar · View at Scopus
  5. J. M. Dekker, C. Girman, T. Rhodes et al., “Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study,” Circulation, vol. 112, no. 5, pp. 666–673, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. E. S. Ford, “Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence,” Diabetes Care, vol. 28, no. 7, pp. 1769–1778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Janghorbani and M. Amini, “Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors,” Metabolic Syndrome and Related Disorders, vol. 5, no. 3, pp. 243–254, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey,” Journal of the American Medical Association, vol. 287, no. 3, pp. 356–359, 2002. View at Google Scholar · View at Scopus
  10. C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, “NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older,” Diabetes, vol. 52, no. 5, pp. 1210–1214, 2003. View at Publisher · View at Google Scholar
  11. M. Janghorbani, M. Amini, H. Ghanbari, and H. Safaiee, “Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran,” Ophthalmic Epidemiology, vol. 10, no. 2, pp. 81–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Janghorbani and M. Amini, “Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors,” Ophthalmic Epidemiology, vol. 11, no. 5, pp. 347–358, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Recenti Progressi in Medicina, no. 1, supplement, pp. S55–S60, 2008. View at Google Scholar
  14. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  15. N. Sattar, A. Gaw, O. Scherbakova et al., “Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study,” Circulation, vol. 108, no. 4, pp. 414–419, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. Li, H. Yatsuya, H. Iso, K. Tamakoshi, and H. Toyoshima, “Incidence of metabolic syndrome according to combinations of lifestyle factors among middle-aged Japanese male workers,” Preventive Medicine, vol. 51, no. 2, pp. 118–122, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  18. E. Bonora, S. Kiechl, J. Willeit et al., “Prevalence of insulin resistance in metabolic disorders: the Bruneck Study,” Diabetes, vol. 47, no. 10, pp. 1643–1649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. A. O. Rantala, H. Kauma, M. Lilja, M. J. Savolainen, A. Reunanen, and Y. A. Kesäniemi, “Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects,” Journal of Internal Medicine, vol. 245, no. 2, pp. 163–174, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Fakhrzadeh, P. Ebrahimpour, R. Pourebrahim, R. Heshmat, and B. Larijani, “Metabolic syndrome and its associated risk factors in healthy adults: a population-based study in Iran,” Metabolic Syndrome and Related Disorders, vol. 4, no. 1, pp. 28–34, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. F. Azizi, P. Salehi, A. Etemadi, and S. Zahedi-Asl, “Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study,” Diabetes Research and Clinical Practice, vol. 61, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Balkau, M. A. Charles, T. Drivsholm et al., “Frequency of the who metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome,” Diabetes and Metabolism, vol. 28, no. 5, pp. 364–376, 2002. View at Google Scholar
  23. L. A. Costa, L. H. Canani, H. R. K. Lisbôa, G. S. Tres, and J. L. Gross, “Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes,” Diabetic Medicine, vol. 21, no. 3, pp. 252–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. J. Lee and J. C. R. Tsai, “ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients,” Diabetes Care, vol. 25, no. 6, pp. 1002–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Ilanne-Parikka, J. G. Eriksson, J. Lindström et al., “Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort,” Diabetes Care, vol. 27, no. 9, pp. 2135–2140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Nakanishi, K. Suzuki, and K. Tatara, “Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men,” Diabetes Care, vol. 27, no. 6, pp. 1427–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. C. Santos, M. Severo, and H. Barros, “Incidence and risk factors for the metabolic syndrome in an urban South European population,” Preventive Medicine, vol. 50, no. 3, pp. 99–105, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Scuteri, C. H. Morrell, S. S. Najjar et al., “Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore longitudinal study of aging,” Journals of Gerontology Series A, vol. 64, no. 5, pp. 590–598, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L. Palaniappan, M. R. Carnethon, Y. Wang et al., “Predictors of the incident metabolic syndrome in adults: the insulin resistance atherosclerosis study,” Diabetes Care, vol. 27, no. 3, pp. 788–793, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. S. Han, K. Williams, N. Sattar, K. J. Hunt, M. E. J. Lean, and S. M. Haffner, “Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study,” Obesity Research, vol. 10, no. 9, pp. 923–931, 2002. View at Google Scholar · View at Scopus
  31. S. Ryu, J. Song, B. Y. Choi et al., “Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39,” Annals of Epidemiology, vol. 17, no. 4, pp. 245–252, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. W. H. H. Sheu, S. Y. Chuang, W. J. Lee, S. T. Tsai, P. Chou, and C. H. Chen, “Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan,” Diabetes Research and Clinical Practice, vol. 74, no. 2, pp. 162–168, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. B. Balkau, M. Vernay, L. Mhamdi et al., “The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study,” Diabetes and Metabolism, vol. 29, no. 5, pp. 526–532, 2003. View at Google Scholar · View at Scopus
  34. V. A. Fonseca, “The metabolic syndrome, hyperlipidemia, and insulin resistance,” Clinical Cornerstone, vol. 7, no. 2-3, pp. 61–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. R. Carnethon, C. M. Loria, J. O. Hill, S. Sidney, P. J. Savage, and K. Liu, “Risk factors for metabolic syndrome. The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001,” Diabetes Care, vol. 27, no. 11, pp. 2707–2715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Amini, N. Bashardost, M. Kazemi, M. Shahparian, F. Afshinnia, and M. Kabirzadeh, “Risk factors of diabetes mellitus among Isfahan city population aged over 40,” Journal of Research In Medical Sciences, vol. 2, pp. 3–7, 1998. View at Google Scholar
  37. A. H. Kissebah, N. Vydelingum, and R. Murray, “Relation of body fat distribution to metabolic complications of obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 54, no. 2, pp. 254–260, 1982. View at Google Scholar
  38. M. Krotkiewski, P. Bjorntorp, L. Sjostrom, and U. Smith, “Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution,” Journal of Clinical Investigation, vol. 72, no. 3, pp. 1150–1162, 1983. View at Google Scholar · View at Scopus
  39. Y. Matsuzawa, T. Nakamura, M. Takahashi et al., “New criteria for “obesity disease” in Japan,” Circulation Journal, vol. 66, no. 11, pp. 987–992, 2002. View at Publisher · View at Google Scholar